Does des-acyl ghrelin improve glycemic control in obese diabetic subjects by decreasing acylated ghrelin levels?

European Journal of Endocrinology

Volumn 170, Issue 6, 2014, Pages 799-807

  Özcan, Behiye ^a   Neggers, Sebastian J C M M ^a   Miller, Anne Reifel ^b   Yang, Hsiu Chiung ^b   Lucaites, Virginia ^b   Abribat, Thierry ^c   Allas, Soraya ^c   Huisman, Martin ^a   Visser, JennyA ^a   Themmen, AxelP N ^a   Sijbrands, EricJ G ^a   Delhanty, Patric J D ^a   Van Der Lely, Aart Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ELI LILLY AND COMPANY   (United States)

^c Alizé Pharma   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATED GHRELIN; DESACYLGHRELIN; GASTROINTESTINAL HORMONE; GLUCOSE; INSULIN; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEADACHE; HUMAN; INSULIN RESPONSE; INSULIN SENSITIVITY; INTERVENTION STUDY; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACYLATION; ADULT; BLOOD GLUCOSE; DOWN-REGULATION; FEMALE; GHRELIN; GLUCOSE CLAMP TECHNIQUE; HUMANS; MALE; MEALS; MIDDLE AGED; OBESITY;

EID: 84902603186     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0347     Document Type: Article

References (37)

1. Delhanty PJ & van der Lely AJ. Ghrelin and glucose homeostasis. Peptides 2011 32 2309-2318. (doi:10.1016/j.peptides.2011.03.001)
2. Gauna C, Delhanty PJ, Hofland LJ, Janssen J, Broglio F, Ross RJ, Ghigo E & van der Lely AJ. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. Journal of Clinical Endocrinology and Metabolism 2005 90 1055-1060. (doi:10.1210/jc.2004-1069)
3. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, van der Lely AJ & Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism 2004 89 3062-3065. (doi:10.1210/jc.2003- 031964)
4. Gauna C, Meyler FM, Janssen J, Delhanty PJD, Abribat T, Van Koetsveld P, Hofland LJ, Broglio F, Ghigo E & van der Lely AJ. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2004 89 5035-5042. (doi:10.1210/jc.2004-0363)
5. Kiewiet R, van Aken M, van der Weerd K, Uitterlinden P, Themmen A, Hofland L, de Rijke Y, Delhanty P, Ghigo E, Abribat T et al. Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes. European Journal of Endocrinology 2009 161 567-573. (doi:10.1530/EJE-09-0339)
6. Gauna C, Kiewiet RM, Janssen JA, van de Zande B, Delhanty PJ, Ghigo E, Hofland LJ, Themmen AP & van der Lely AJ. Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions. American Journal of Physiology. Endocrinology and Metabolism 2007 293 E697-E704. (doi:10.1152/ajpendo.00219.2007)
7. Benso A, St-Pierre DH, Prodam F, Gramaglia E, Granata R, van der Lely AJ, Ghigo E & Broglio F. Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. European Journal of Endocrinology 2012 166 911-916. (doi:10.1530/EJE-11-0982)
8. Longo KA, Charoenthongtrakul S, Giuliana DJ, Govek EK, McDonagh T, Qi Y, DiStefano PS & Geddes BJ. Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. Regulatory Peptides 2008 150 55-61. (doi:10.1016/j.regpep.2008.03.011)
9. Pacifico L, Anania C, Poggiogalle E, Osborn JF, Prossomariti G, Martino F & Chiesa C. Relationships of acylated and des-acyl ghrelin levels to bone mineralization in obese children and adolescents. Bone 2009 45 274-279. (doi:10.1016/j.bone.2009.04.204)
10. St-Pierre DH, Karelis AD, Coderre L, Malita F, Fontaine J, Mignault D, Brochu M, Bastard JP, Cianflone K, Doucet E et al . Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2007 92 264-269. (doi:10.1210/jc.2006-1603)
11. Barazzoni R, Zanetti M, Ferreira C, Vinci P, Pirulli A, Mucci M, Dore F, Fonda M, Ciocchi B, Cattin L et al. Relationships between desacylated and acylated ghrelin and insulin sensitivity in themetabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 3935-3940. (doi:10.1210/jc.2006- 2527)
12. Rodriguez A, Gomez-Ambrosi J, Catalan V, Becerril S, Sainz N, Gil MJ, Silva C, Salvador J, Barba J, Colina I et al. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. Journal of Hypertension 2010 28 560-567. (doi:10.1097/HJH. 0b013e328334327c)
13. DeFronzo RA, Tobin JD & Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 1979 237 E214-E223. (Pubitemid 9249478)
14. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care 2011 34 (Suppl 1) S11-S61. (doi:10.2337/dc11-S011)
15. Allen NA, Fain JA, Braun B & Chipkin SR. Continuous glucose monitoring in non-insulin-using individuals with type 2 diabetes: acceptability, feasibility, and teaching opportunities. Diabetes Technology & Therapeutics 2009 11 151-158. (doi:10.1089/dia.2008.0053)
16. Gibson W, Liu J, Gaylinn B, Thorner MO, Meneilly GS, Babich SL, Thompson D & Chanoine JP. Effects of glucose and insulin on acyl ghrelin and desacyl ghrelin, leptin, and adiponectin in pregnant women with diabetes. Metabolism 2010 59 841-847. (doi:10.1016/j.metabol.2009.09.033)
17. Weickert MO, Loeffelholz CV, Arafat AM, Schofl C, Otto B, Spranger J, Mohlig M & Pfeiffer AF. Euglycemic hyperinsulinemia differentially modulates circulating total and acylated-ghrelin in humans. Journal of Endocrinological Investigation 2008 31 119-124. (Pubitemid 351596971)
18. Paik KH, Choe YH, Park WH, Oh YJ, Kim AH, Chu SH, Kim SW, Kwon EK, Han SJ, Shon WY et al. Suppression of acylated ghrelin during oral glucose tolerance test is correlated with whole-body insulin sensitivity in children with Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism 2006 91 1876-1881. (doi:10.1210/jc.2005-2168)
19. Goldstone AP, Holland AJ, Butler JV & Whittington JE. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. International Journal of Obesity 2012 36 1564-1570. (doi:10.1038/ijo.2011.274)
20. Miegueu P, St Pierre D, Broglio F & Cianflone K. Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. Journal of Cellular Biochemistry 2011 112 704-714. (doi:10.1002/jcb.22983)
21. Inhoff T, Monnikes H, Noetzel S, Stengel A, Goebel M, Dinh QT, Riedl A, Bannert N, Wisser AS, Wiedenmann B et al. Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 2008 29 2159-2168. (doi:10.1016/j.peptides.2008.09.014)
22. Mackelvie KJ, Meneilly GS, Elahi D, Wong AC, Barr SI & Chanoine JP. Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin. Journal of Clinical Endocrinology and Metabolism 2007 92 648-654. (doi:10.1210/jc.2006-1028)
23. Kim HJ, Lee S, Kim TW, Kim HH, Jeon TY, Yoon YS, Oh SW, Kwak H & Lee JG. Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children. Clinical Endocrinology 2008 68 416-422. (Pubitemid 351257861)
24. Barnett BP, Hwang Y, Taylor MS, Kirchner H, Pfluger PT, Bernard V, Lin YY, Bowers EM, Mukherjee C, Song WJ et al. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 2010 330 1689-1692. (doi:10.1126/science.1196154)
25. Cederberg H, Koivisto VM, Jokelainen J, Surcel HM, Keinanen-Kiukaanniemi S & Rajala U. Unacylated ghrelin is associated with changes in insulin sensitivity and lipid profile during an exercise intervention. Clinical Endocrinology 2012 76 39-45. (doi:10.1111/j.1365-2265.2011.04135.x)
26. Maletinska L, Matyskova R, Maixnerova J, Sykora D, Pychova M, Spolcova A, Blechova M, Drapalova J, Lacinova Z, Haluzik M et al. The peptidic GHS-R antagonist [D-Lys(3)]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity. Molecular and Cellular Endocrinology 2011 343 55-62. (doi:10.1016/j.mce.2011.06.006)
27. Landgren S, Engel JA, Hyytia P, Zetterberg H, Blennow K & Jerlhag E. Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference. Behavioural Brain Research 2011 221 182-188. (doi:10.1016/j.bbr.2011.03.003)
28. Landgren S, Simms JA, Thelle DS, Strandhagen E, Bartlett SE, Engel JA & Jerlhag E. The ghrelin signalling system is involved in the consumption of sweets. PLoS ONE 2011 6 e18170. (doi:10.1371/journal.pone.0018170)
29. Landgren S, Simms JA, Hyytia P, Engel JA, Bartlett SE & Jerlhag E. Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. Addiction Biology 2012 17 86-94. (doi:10.1111/j.1369-1600.2010.00280.x)
30. Kirchner H, Heppner KM, Holland J, Kabra D, Tschop MH & Pfluger PT. Ablation of ghrelin O-acyltransferase does not improve glucose intolerance or body adiposity in mice on a leptin-deficient ob/ob background. PLoS ONE 2013 8 e61822. (doi:10.1371/journal.pone.0061822)
31. Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, Valenzuela DM, Yancopoulos GD, Goldstein JL & Brown MS. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. PNAS 2010 107 7467-7472. (doi:10.1073/pnas.1002271107)
32. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, Meguid MM & Kasuga M. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005 54 18-24. (doi:10.1136/gut.2004.038737)
33. Zhang W, Chai B, Li JY, Wang H & Mulholland MW. Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology 2008 149 4710-4716. (doi:10.1210/en.2008-0263)
34. Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Martinetti M, Catapano F et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic β-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 2007 148 512-529. (doi:10.1210/en.2006-0266)
35. Delhanty PJ, Sun Y, Visser JA, van Kerkwijk A, Huisman M, van Ijcken WF, Swagemakers S, Smith RG, Themmen AP & van der Lely AJ. Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS ONE 2010 5 e11749. (doi:10.1371/journal.pone.0011749)
36. Lear PV, Iglesias MJ, Feijoo-Bandin S, Rodriguez-Penas D, Mosquera-Leal A, Garcia-Rua V, Gualillo O, Ghe C, Arnoletti E, Muccioli G et al. Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. Endocrinology 2010 151 3286-3298. (doi:10.1210/en.2009-1205)
37. Ariyasu H, Takaya K, Iwakura H, Hosoda H, Akamizu T, Arai Y, Kangawa K & Nakao K. Transgenicmice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 2005 146 355-364. (doi:10.1210/en.2004-0629)